Boston Scientific invests in ICD (implantable cardioverter defibrillator) developer Cameron Health
This article was originally published in Clinica
Boston Scientific made its second equity investment of the week on February 20 when it agreed to take a stake in Cameron Health. The San Clemente, California-based firm is developing a novel implantable cardioverter defibrillator (ICD).
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.